Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000122

Chief Medical Officer sold 1,989 shares at an average $37.53 ($74,642)

  • Chief Medical Officer acquired 1,989 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gheuens Sarah · Chief Medical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-21 Exercise or conversion : show line 1 in the form 10b5-1 +1,489 $25.01 $37,240 56,134 D
2026-10-21 Sale : show line 2 in the form 10b5-1 −1,489 $37.53 $55,882 54,645 D
2026-10-22 Exercise or conversion : show line 3 in the form 10b5-1 +500 $25.01 $12,505 55,145 D
2026-10-22 Sale : show line 4 in the form 10b5-1 −500 $37.52 $18,760 54,645 D
Open-market sales · 1,989 sh · avg $37.53 · $74,642

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-10-21 Exercise or conversion : show line 5 in the form 10b5-1 Stock options (right to buy) −1,489 24,641 D
2026-10-22 Exercise or conversion : show line 6 in the form 10b5-1 Stock options (right to buy) −500 24,141 D
Loading xslF345X06/wk-form4_1792785942.xml…